Numantec / News
News
With a focus on innovation and the strengthening of a sector that is constantly growing and evolving, NUMANTEC was established—a new biomedical group composed of various entities specialized in healthcare assistance solutions.
Many of the most common complications in vascular access, such as infections, occlusions, dislodgement, and malposition, do not depend solely...
In the management of critically ill patients, and in clinical settings that require continuous haemodynamic monitoring, arterial access enables accurate...
From 15 to 17 April 2026, the Numantec Group will take part in the 9th World Congress on Vascular Access...
The management of intra-abdominal pressure (IAP) is a critical aspect of monitoring critically ill patients, particularly in intensive care units....
PICC: Clinical Evidence and Updated Data on Use in Vascular Access
Modern vascular access practice is based not only on device selection, but above all on a structured decision-making process that...
Numantec, via its US subsidiary Health Line International Corp, acquires the DualCap® product line from Merit Medical Systems, Inc.
Salt Lake City, Utah – February 25, 2026 – Numantec (“Numantec” or “Group”), a global manufacturer of infusion therapy medical...
The Benefits and Potential of Technology at the Bedside
The integration of technology into hospital wards has profoundly transformed the way patients are cared for. For companies like Numantec,...
Numantec at WHX Dubai 2026, 9–12 February
Arab Health evolves into the World Health Expo – WHX Dubai, marking a new identity for one of the most...
PentaFlush® Pre-filled Saline Syringes
In response to the growing demand for greater efficiency in healthcare, the Numantec Group offers the PentaFlush® line: pre-filled syringes...
